---
schema_version: "secwatch.filing_event.v1"
accession: "0001903596-23-000804"
form_type: "8-K"
ticker: "KAYS"
cik: "0001530746"
company_name: "Kaya Holdings, Inc."
filed_at: "2023-10-23T23:59:59+00:00"
generated_at: "2026-06-09T16:37:45.648462+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# KAYS closes additional $600K non-dilutive bridge financing for Oregon psilocybin center

## Summary
- Total bridge financing since June 2023 is $600K: $100K short-term due Mar 15, 2023, $500K repayable from 10% of quarterly revenues, balance due Jun 30, 2025.
- Funds are non-dilutive, not convertible into stock, and carry no commissions or fees.
- Company expects to submit Oregon Health Authority license application in 30 days and open The Sacred Mushroom facility within 90 days of approval.
- The 11,000 sq ft facility will include a microdosing café, private treatment rooms, group areas, and activity zones aiming for lower pricing than competitors.
- KAYS believes it is the only U.S. public company pursuing an OHA psilocybin treatment center license.

## SEC filing metadata
- accession: 0001903596-23-000804
- form_type: 8-K
- ticker: KAYS
- cik: 0001530746
- company_name: Kaya Holdings, Inc.
- filed_at: 2023-10-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1530746/000190359623000804/0001903596-23-000804-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1530746/000190359623000804/kays_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001903596-23-000804
- JSON: https://secwatch.observer/filing/0001903596-23-000804.json
- Plain text: https://secwatch.observer/filing/0001903596-23-000804.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.